Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity

by Sandra van Wilpe, Sofie H. Tolmeijer, Rutger H. T. Koornstra, I. Jolanda M. de Vries, Winald R. Gerritsen, Marjolijn Ligtenberg, Niven Mehra
Published 2021-05-01

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

by Winald R Gerritsen, Johannes Textor, Niven Mehra, Jeroen H A Creemers, W Joost Lesterhuis, Carl G Figdor, I Jolanda M de Vries
Published 2021-05-01

Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder

by Sandra van Wilpe, Eveline C. F. Gerretsen, Antoine G. van der Heijden, I. Jolanda M. de Vries, Winald R. Gerritsen, Niven Mehra
Published 2020-09-01

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

by Harm Westdorp, Harm Westdorp, Jeroen H. A. Creemers, Jeroen H. A. Creemers, Inge M. van Oort, Niven Mehra, Niven Mehra, Simone M. Hins-de Bree, Carl G. Figdor, Carl G. Figdor, J. Alfred Witjes, Gerty Schreibelt, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Winald R. Gerritsen, Winald R. Gerritsen, Petronella B. Ottevanger
Published 2020-10-01

Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer.

by Daniela E Oprea-Lager, Andrew D Vincent, Reindert J A van Moorselaar, Winald R Gerritsen, Alfons J M van den Eertwegh, Jonas Eriksson, Ronald Boellaard, Otto S Hoekstra
Published 2012-01-01

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

by Wouter W. van Willigen, Wouter W. van Willigen, Martine Bloemendal, Martine Bloemendal, Winald R. Gerritsen, Gerty Schreibelt, I. Jolanda M. de Vries, Kalijn F. Bol, Kalijn F. Bol
Published 2018-10-01

Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer

by Minke Smits, Kamer Ekici, Samhita Pamidimarri Naga, Inge M. van Oort, Michiel J. P. Sedelaar, Jack A. Schalken, James Nagarajah, Tom W. J. Scheenen, Winald R. Gerritsen, Jurgen J. Fütterer, Niven Mehra
Published 2020-12-01

Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial Cancer

by Sandra van Wilpe, Victoria Wosika, Laura Ciarloni, Sahar Hosseinian Ehrensberger, Rachel Jeitziner, Paolo Angelino, Tjitske Duiveman-de Boer, Rutger H. T. Koornstra, I. Jolanda M. de Vries, Winald R. Gerritsen, Jack Schalken, Niven Mehra
Published 2021-09-01

Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma

by Sofie H. Tolmeijer, Rutger H. T. Koornstra, Jan Willem B. de Groot, Maartje J. Geerlings, Dirk H. van Rens, Marye J. Boers-Sonderen, Jack A. Schalken, Winald R. Gerritsen, Marjolijn J. L. Ligtenberg, Niven Mehra
Published 2021-08-01

Immunotherapy for prostate cancer: Lessons from responses to tumor-associated antigens

by Harm eWestdorp, Harm eWestdorp, Annette E. Skold, Berit A. Snijer, Sebastian eFranik, Sasja F. Mulder, Pierre Paul Major, Ronan eFoley, Winald R. Gerritsen, I. Jolanda M. de Vries, I. Jolanda M. de Vries
Published 2014-05-01

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

by Wouter W. van Willigen, Martine Bloemendal, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Rutger H.T. Koornstra, Astrid A.M. van der Veldt, John B. A. G. Haanen, Steve Boudewijns, Gerty Schreibelt, Winald R. Gerritsen, I. Jolanda M. de Vries, Kalijn F. Bol
Published 2020-01-01

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

by Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort, Gerty Schreibelt, Mark A. J. Gorris, Niven Mehra, Michiel Simons, Anna L. de Goede, Michelle M. van Rossum, Alexandra J. Croockewit, Carl G. Figdor, J. Alfred Witjes, Erik H. J. G. Aarntzen, Roel D. M. Mus, Mareke Brüning, Katja Petry, Martin Gotthardt, Jelle O. Barentsz, I. Jolanda M. de Vries, Winald R. Gerritsen
Published 2019-11-01

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

by Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Published 2020-09-01